Pneumonia Vaccine for 50+

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Pneumonia Vaccine for 50+

50+ Years Old & Older, Males & Females

The main purpose of this clinical trial is to compare 3 vaccines; PPSV23 (currently marketed as PNEUMOVAX23) vs V116 (investigational pneumonia vaccine covering more serotypes) vs PCV15 (currently marketed as VAXNEUVANCE). These vaccines serve to protect humans against pneumonia or severe symptoms of pneumonia.

Eligibility
  • Previous pneumonia vaccine over 12 months ago
  • Cannot have an autoimmune disease
  • Cannot be undergoing current cancer treatment
Trial Duration

2 office visits (2nd appt is 30 days after the 1st) over approximately 6 months

Compensation

May receive $150 per completed office visit and $25 per completed telephone visit

Apply for this Study & take the first step towards better care for yourself today.

MM slash DD slash YYYY
Address
May we text you?
Preferred method of contact:
Preferred Time to Reach You:
Please select the current clinical trial(s) that interest you:
Please select the upcoming trial(s) that interest you:
Please select all that pertain to your current medical history: